在老年人中长期暴露于空气污染和步行速度下降的成年人:纵向分析
Boeun Kim1, Anjum Hajat2, Amanda J Gassett2
1College of Nursing, University of Iowa, Iowa City, IA, USA.
Environmental research
|November 22, 2025
概括
长期暴露于细颗粒物 (PM2.5) 和二氧化 (NO2) 显著加快了老年人的步行速度下降. 减少空气污染暴露对于保持流动性和预防相关健康风险至关重要.
科学领域:
- 环境健康 环境健康
- 老年学是一门学科.
- 流行病学 流行病学
背景情况:
- 长期暴露于空气污染可能会通过炎症,氧化应激和功能障碍损害步行速度.
- 研究细颗粒物 (PM2.5) 和二氧化 (NO2) 对随时间变化的步行速度的影响.
研究的目的:
- 检查长期暴露于PM2.5和NO2与步行速度下降之间的关联.
- 分析不同时间窗口 (研究前和并发) 的暴露及其对步行速度的影响.
主要方法:
- 利用了Ginkgo评估记忆研究 (GEMS) 的数据,对2850名参与者进行了长达6年的随访.
- 使用时空模型评估年度步行速度 (通常和最大步伐) 和估计的空气污染水平 (PM2.5,NO2).
- 采用线性混合效应模型,对相关共变量进行调整.
主要成果:
- 在进入研究之前,20年PM2.5的IQR增加与正常步行速度的0.038m/s下降相关.
- 在进入研究之前10年的NO2 IQR增加与正常步行速度的0.077 m/s下降有关.
- 对于最大步行速度和同时暴露期间观察到类似的关联.
结论:
- 长期暴露于PM2.5和NO2与老年人的步行速度显著下降有关.
- 调查结果强调了环境因素在保持流动性方面的重要性.
- 解决空气污染问题对于保持身体功能和减少不良健康后果至关重要.
相关概念视频
Longitudinal Research
13.0K
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
13.0K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
223
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
223
Pharmacodynamics in Geriatric Patients: Effects of Age
180
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
180
COPD: Management Using Bronchodilators and Corticosteroids
706
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
706
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
212
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
212


